National Trends in Extended Procedures for Ovarian Cancer Debulking Surgery

Abstract

Although there was a transient decrease in the use of extended cytoreductive procedures from 2010 to 2011 after the publication of randomized neoadjuvant trial data, use of these procedures again rose in 2012 and 2013.

Neoadjuvant chemotherapy in high-risk ovarian cancer patients: Role of age

“…Because of debate brought up around these trials, the use of PDS rose once again in 2012 and 2013. 20…”

Outcomes of Hysterectomy Performed by Very Low-Volume Surgeons

“…We also analyzed the indications for the procedure and recorded the following diagnoses based on ICD-9 coding: leiomyoma, endometriosis, abnormal menstruation and bleeding, benign neoplasms and cysts, pelvic organ prolapse, endometrial hyperplasia with and without atypia, uterine cancer, cervical cancer, and ovarian/fallopian/peritoneal cancers. 23…”

Readmissions after ovarian cancer cytoreduction surgery: The first 30 days and beyond

“…The ECI algorithm uses ICD‐9 and ICD‐10 codes to identify 30 comorbidities validated for use in administrative databases 13 . Extended procedures were defined using previously published methods by Jones et al 14 and encompassed any procedure involving concomitant resection of the stomach, spleen, liver, diaphragm, small or large bowel, or rectosigmoid colon, or any procedure resulting in ileostomy or colostomy.…”